Han-Oh Park
Directeur Général chez BIONEER CORPORATION
Fortune : 87 M $ au 30/04/2024
Profil
Han-Oh Park currently works at BIONEER Corp., as Chief Executive Officer & Director from 2011, Korea Biotechnology Industry Organization, as Vice Chairman from 2002, Bioneer, Inc., as Director, Resource Ventures, Ltd.
(KR), as Director, AceBiomed, Inc., as Director, and Sirnagen Therapetics Co. Ltd., as Director.
Dr. Park received his undergraduate degree from Seoul National University and graduate degree and doctorate degree from Korea Advanced Institute of Science & Technology.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
BIONEER CORPORATION
15,25% | 28/03/2024 | 3 936 997 ( 15,25% ) | 87 M $ | 30/04/2024 |
Postes actifs de Han-Oh Park
Sociétés | Poste | Début |
---|---|---|
BIONEER CORPORATION | Directeur Général | 01/08/1992 |
Bioneer, Inc.
Bioneer, Inc. Miscellaneous Commercial ServicesCommercial Services Bioneer, Inc. engages in the provision of solutions to the community of life science researchers in academia, biotech, and pharmaceutical companies. It offers protein expression and purification, gene synthesis service, ladders and markers, and drug target and toxicity identification services. The company is headquartered in Alameda, CA. | Directeur/Membre du Conseil | - |
Resource Ventures, Ltd. (KR)
Resource Ventures, Ltd. (KR) BiotechnologyHealth Technology Resource Ventures, Ltd. (KR) is a South Korean biotechnology company. | Directeur/Membre du Conseil | - |
Korea Biotechnology Industry Organization | Directeur/Membre du Conseil | 01/01/2002 |
AceBiomed, Inc.
AceBiomed, Inc. Medical SpecialtiesHealth Technology AceBiomed, Inc. is engaged in the manufacturing of medical equipment. The company was founded on April 3, 2001 and is headquartered in Jinju-si, South Korea. | Directeur/Membre du Conseil | - |
Sirnagen Therapetics Co. Ltd.
Sirnagen Therapetics Co. Ltd. Information Technology ServicesTechnology Services Sirnagen Therapeutics Co. Ltd. is a South Korean company that operates as a seed stage RNAi platform technology company. | Directeur/Membre du Conseil | - |
Formation de Han-Oh Park
Seoul National University | Undergraduate Degree |
Korea Advanced Institute of Science & Technology | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
BIONEER CORPORATION | Health Technology |
Entreprise privées | 5 |
---|---|
Bioneer, Inc.
Bioneer, Inc. Miscellaneous Commercial ServicesCommercial Services Bioneer, Inc. engages in the provision of solutions to the community of life science researchers in academia, biotech, and pharmaceutical companies. It offers protein expression and purification, gene synthesis service, ladders and markers, and drug target and toxicity identification services. The company is headquartered in Alameda, CA. | Commercial Services |
Resource Ventures, Ltd. (KR)
Resource Ventures, Ltd. (KR) BiotechnologyHealth Technology Resource Ventures, Ltd. (KR) is a South Korean biotechnology company. | Health Technology |
Korea Biotechnology Industry Organization | |
AceBiomed, Inc.
AceBiomed, Inc. Medical SpecialtiesHealth Technology AceBiomed, Inc. is engaged in the manufacturing of medical equipment. The company was founded on April 3, 2001 and is headquartered in Jinju-si, South Korea. | Health Technology |
Sirnagen Therapetics Co. Ltd.
Sirnagen Therapetics Co. Ltd. Information Technology ServicesTechnology Services Sirnagen Therapeutics Co. Ltd. is a South Korean company that operates as a seed stage RNAi platform technology company. | Technology Services |